Literature DB >> 11287174

In vitro long-term cytotoxicity testing of 27 MEIC chemicals on Hep G2 cells and comparison with acute human toxicity data.

E M Scheers1, B Ekwall, P J Dierickx.   

Abstract

Within the framework of the EDIT (Evaluation guided Development of In vitro Toxicity and toxicokinetic tests) programme, the long-term cytotoxicity of 27 chemicals was investigated on Hep G2 cells. The first step in the experiments was to determine the PI50(24h) of the chemicals. This is the concentration of compound needed to reduce the total protein content by 50% after 24 h of treatment. In the long-term experiments the chemicals were tested in six different concentrations, using the PI50(24h) as maximum concentration. The cells were treated twice a week with the same concentration of test compound and were trypsinised and counted once a week (dynamic culture). The number of cells was compared to the number of cells of the control. Three major long-term cytotoxicity patterns could be distinguished. After 6 weeks, the EC50(6w)s were determined. This is the concentration of compound needed to reduce the number of cells by 50% after 6 weeks of treatment. These values were compared with the PI50(24h). A good correlation was found for the 27 chemicals (r(2)=0.860). After 6 weeks, the concentration of test compound needed to reduce the total cell protein content by 50% after 24 h after 6 weeks of pretreatment of the cells with a particular concentration of test compound was measured: the PI50(24h-6w). For the majority of compounds there is no difference between the PI50(24h) and the PI50(24h-6w). For ethanol, arsenic (III) oxide, verapamil hydrochloride and orphenadrine, the PI50(24h-6w) increased in comparison to the PI50(24h). For some compounds a doseresponse was observed, indicating that the cells have become more resistant or more sensitive. Linear regression analysis revealed a good correlation (r(2)=0.709) between the EC50(6w) and the human acute toxicity. All these data indicate that a good alternative test may be found for predicting the long-term human toxicity.

Entities:  

Mesh:

Year:  2001        PMID: 11287174     DOI: 10.1016/s0887-2333(00)00062-x

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  15 in total

1.  Toxicity of antimony, copper, cobalt, manganese, titanium and zinc oxide nanoparticles for the alveolar and intestinal epithelial barrier cells in vitro.

Authors:  T Titma; R Shimmo; J Siigur; A Kahru
Journal:  Cytotechnology       Date:  2016-10-19       Impact factor: 2.058

2.  PP2A ligand ITH12246 protects against memory impairment and focal cerebral ischemia in mice.

Authors:  Silvia Lorrio; Alejandro Romero; Laura González-Lafuente; Rocío Lajarín-Cuesta; Francisco J Martínez-Sanz; Martín Estrada; Abdelouahid Samadi; Jose Marco-Contelles; María Isabel Rodríguez-Franco; Mercedes Villarroya; Manuela G López; Cristóbal de los Ríos
Journal:  ACS Chem Neurosci       Date:  2013-06-13       Impact factor: 4.418

3.  A comparison of CRISPR/Cas9 and siRNA-mediated ALDH2 gene silencing in human cell lines.

Authors:  Fei Wang; Tao Guo; Hongmei Jiang; Ruobi Li; Ting Wang; Ni Zeng; Guanghui Dong; Xiaowen Zeng; Daochuan Li; Yongmei Xiao; Qiansheng Hu; Wen Chen; Xiumei Xing; Qing Wang
Journal:  Mol Genet Genomics       Date:  2018-01-30       Impact factor: 3.291

4.  Chemopreventive effect of 18β-glycyrrhetinic acid via modulation of inflammatory markers and induction of apoptosis in human hepatoma cell line (HepG2).

Authors:  Syed Kazim Hasan; Aisha Siddiqi; Sana Nafees; Nemat Ali; Summya Rashid; Rashid Ali; Ayaz Shahid; Sarwat Sultana
Journal:  Mol Cell Biochem       Date:  2016-04-26       Impact factor: 3.396

5.  Identification of small molecule lead compounds for visceral leishmaniasis using a novel ex vivo splenic explant model system.

Authors:  Yaneth Osorio; Bruno L Travi; Adam R Renslo; Alex G Peniche; Peter C Melby
Journal:  PLoS Negl Trop Dis       Date:  2011-02-15

6.  Toxicity assays in nanodrops combining bioassay and morphometric endpoints.

Authors:  Frédéric Lemaire; Céline A Mandon; Julien Reboud; Alexandre Papine; Jesus Angulo; Hervé Pointu; Chantal Diaz-Latoud; Christian Lajaunie; François Chatelain; André-Patrick Arrigo; Béatrice Schaack
Journal:  PLoS One       Date:  2007-01-17       Impact factor: 3.240

7.  Immunomodulating and Antitumor Activities of Panellus serotinus Polysaccharides.

Authors:  Jeong Hwa Kim; Jae Seong Lee; Kyung Rim Lee; Mi Ja Shim; Min Woong Lee; Pyung Gyun Shin; Jong Chun Cheong; Young Bok Yoo; Tae Soo Lee
Journal:  Mycobiology       Date:  2012-09-30       Impact factor: 1.858

8.  Toxicity of a novel herbomineral preparation las01 on human cancer cell lines and its safety profile in humans and animals.

Authors:  Saba Sheikh; Ashok Srivastava; Rajesh Tripathi; Shalini Tripathi; V P Trivedi; R C Saxena
Journal:  Evid Based Complement Alternat Med       Date:  2012-08-30       Impact factor: 2.629

9.  Anticancer and Immunopotentiating Activities of Crude Polysaccharides from Pleurotus nebrodensis on Mouse Sarcoma 180.

Authors:  Youn Jeong Cha; Nuhu Alam; Jae Seong Lee; Kyung Rim Lee; Mi Ja Shim; Min Woong Lee; Hye Young Kim; Pyung Gyun Shin; Jong Chun Cheong; Young Bok Yoo; Tae Soo Lee
Journal:  Mycobiology       Date:  2012-12-26       Impact factor: 1.858

10.  In vitro cytotoxicity and in vivo acute and chronic toxicity of Xanthii Fructus and its processed product.

Authors:  Jie Yu; Mei-Zhen Song; Jing Wang; Yun-Fei Li; Pei Lin; Lin Que; Zhaorigetu Bao
Journal:  Biomed Res Int       Date:  2013-11-26       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.